Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 2, 2009, Pages 138-146

  Iwakami, Yuko ^a   Sakuraba, Atsushi ^a   Sato, Toshiro ^a   Takada, Yasuhiro ^a   Izumiya, Motoko ^a   Ichikawa, Hitoshi ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendritic cell; Granulocyte and monocyte adsorption apheresis; Ulcerative colitis

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CORTICOSTEROID; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 4; MESALAZINE;

ADSORPTION; ADULT; ALLOTYPE; APHERESIS; ARTICLE; BLOOD; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; GRANULOCYTE AND MONOCYTE ADSORPTION APHERESIS; HUMAN; HUMAN TISSUE; MALE; MIXED LYMPHOCYTE REACTION; MOLECULAR DYNAMICS; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TREATMENT RESPONSE; ULCERATIVE COLITIS; VENOUS BLOOD;

ADULT; AGED; BLOOD COMPONENT REMOVAL; COLITIS, ULCERATIVE; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; T-LYMPHOCYTES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63349108375     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00668.x     Document Type: Article

References (29)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
2. Hart AL, Al-Hassi HO, Rigby RJ et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005 129 : 50 65.
3. Baumgart DC, Metzke D, Schmitz J et al. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005 54 : 228 36.
4. Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 2006 55 : 220 7.
5. Matsuoka K, Inoue N, Sato T et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 2004 53 : 1303 8.
6. Sato T, Nakai T, Tamura N et al. Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 2005 54 : 1254 62.
7. Brannigan AE, O'Connell PR, Hurley H et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 2000 13 : 361 6.
8. Meuret G, Bitzi A, Hammer B. Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology 1978 74 : 501 3.
9. Naganuma M, Funakoshi S, Sakuraba A et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 2004 10 : 251 7.
10. Hiraishi K, Takeda Y, Shiobara N et al. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 2003 7 : 334 40.
11. Hibi T, Sakuraba A. Is there a role for apheresis in gastrointestinal disorders? Nat Clin Pract Gastroenterol Hepatol 2005 2 : 200 1.
12. Andoh A, Tsujikawa T, Inatomi O et al. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis. Ther Apher Dial 2005 9 : 123 7.
13. Kashiwagi N, Nakano M, Saniabadi AR, Adachi M, Yoshikawa T. Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis. Inflammation 2002 26 : 199 205.
14. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994 330 : 1841 5.
15. Shimoyama T, Sawada K, Hiwatashi N et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001 16 : 1 9.
16. Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996 196 : 137 51.
17. Szaflarska A, Baj-Krzyworzeka M, Siedlar M et al. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol 2004 32 : 748 55.
18. Almeida J, Bueno C, Alguero MC et al. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells. Clin Immunol 2001 100 : 325 38.
19. Baeten D, Boots AM, Steenbakkers PG et al. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000 43 : 1233 43.
20. Shin T, Yoshimura K, Shin T et al. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med 2005 201 : 1531 41.
21. Kashiwagi N, Sugimura K, Koiwai H et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002 47 : 1334 41.
22. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res 2004 53 : 277 83.
23. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004 49 : 565 71.
24. Rothe G, Gabriel H, Kovacs E et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996 16 : 1437 47.
25. Belge KU, Dayyani F, Horelt A et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002 168 : 3536 42.
26. Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schakel K. The CD16(+) (FcγRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002 196 : 517 27.
27. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
28. Nguyen LT, Radhakrishnan S, Ciric B et al. Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells. J Exp Med 2002 196 : 1393 8.
29. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999 283 : 1183 6.